Healthpeak Properties, Inc. $DOC Shares Purchased by HF Advisory Group LLC

HF Advisory Group LLC increased its stake in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 27.5% during the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 119,490 shares of the real estate investment trust’s stock after buying an additional 25,747 shares during the quarter. HF Advisory Group LLC’s holdings in Healthpeak Properties were worth $1,963,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in DOC. State Street Corp increased its stake in shares of Healthpeak Properties by 1.8% in the 3rd quarter. State Street Corp now owns 49,498,109 shares of the real estate investment trust’s stock worth $947,889,000 after acquiring an additional 895,460 shares during the last quarter. JPMorgan Chase & Co. boosted its position in shares of Healthpeak Properties by 8.6% during the 4th quarter. JPMorgan Chase & Co. now owns 30,674,812 shares of the real estate investment trust’s stock valued at $493,251,000 after acquiring an additional 2,438,278 shares during the last quarter. Fuller & Thaler Asset Management Inc. boosted its position in shares of Healthpeak Properties by 19.2% during the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 29,648,260 shares of the real estate investment trust’s stock valued at $476,744,000 after acquiring an additional 4,776,056 shares during the last quarter. Geode Capital Management LLC grew its holdings in shares of Healthpeak Properties by 0.6% in the fourth quarter. Geode Capital Management LLC now owns 19,534,041 shares of the real estate investment trust’s stock valued at $312,959,000 after purchasing an additional 123,274 shares during the period. Finally, Invesco Ltd. increased its position in Healthpeak Properties by 9.9% during the fourth quarter. Invesco Ltd. now owns 18,298,776 shares of the real estate investment trust’s stock worth $294,244,000 after purchasing an additional 1,648,012 shares during the last quarter. Institutional investors and hedge funds own 93.57% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have weighed in on DOC shares. Robert W. Baird boosted their target price on shares of Healthpeak Properties from $19.00 to $21.00 and gave the company an “outperform” rating in a report on Wednesday, May 13th. Weiss Ratings raised shares of Healthpeak Properties from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, May 8th. BMO Capital Markets upped their price objective on Healthpeak Properties from $20.00 to $24.00 and gave the company an “outperform” rating in a report on Monday, June 15th. JPMorgan Chase & Co. raised their target price on Healthpeak Properties from $18.00 to $21.00 and gave the stock a “neutral” rating in a research note on Wednesday. Finally, Raymond James Financial assumed coverage on Healthpeak Properties in a research report on Wednesday, June 17th. They issued a “market perform” rating on the stock. Three analysts have rated the stock with a Buy rating and fourteen have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $19.93.

Healthpeak Properties Price Performance

Shares of DOC opened at $21.51 on Friday. The firm has a 50-day simple moving average of $19.06 and a two-hundred day simple moving average of $17.66. The stock has a market cap of $14.83 billion, a PE ratio of 67.22, a P/E/G ratio of 3.31 and a beta of 1.05. Healthpeak Properties, Inc. has a 1-year low of $15.70 and a 1-year high of $21.56. The company has a debt-to-equity ratio of 1.15, a current ratio of 2.96 and a quick ratio of 2.96.

Healthpeak Properties (NYSE:DOC) last issued its quarterly earnings data on Tuesday, May 5th. The real estate investment trust reported $0.45 EPS for the quarter, topping the consensus estimate of $0.43 by $0.02. Healthpeak Properties had a net margin of 7.73% and a return on equity of 2.61%. The firm had revenue of $752.95 million for the quarter, compared to analyst estimates of $694.59 million. During the same period in the prior year, the business posted $0.46 EPS. The business’s revenue for the quarter was up 7.1% compared to the same quarter last year. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. As a group, analysts forecast that Healthpeak Properties, Inc. will post 1.75 EPS for the current year.

Healthpeak Properties Announces Dividend

The company also recently declared a monthly dividend, which was paid on Friday, June 26th. Stockholders of record on Monday, June 15th were given a dividend of $0.1017 per share. This represents a c) annualized dividend and a dividend yield of 5.7%. The ex-dividend date was Monday, June 15th. Healthpeak Properties’s dividend payout ratio (DPR) is currently 381.25%.

Insider Activity at Healthpeak Properties

In other news, insider Scott R. Bohn sold 10,989 shares of Healthpeak Properties stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total value of $213,736.05. Following the completion of the sale, the insider directly owned 7,636 shares of the company’s stock, valued at approximately $148,520.20. The trade was a 59.00% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 0.23% of the stock is currently owned by corporate insiders.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.